Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIRCLE phase 2 trial of ocriplasmin for induction of complete posterior vitreous detachment in non-proliferative diabetic retinopathy
MOH_2017-06-15_000119Phase 2Recruiting
- Sponsor
- Oxurion
- Start
- Aug 2016
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ocriplasmin in diabetic retinopathy (DR) (3 arms), sponsored by Oxurion. Started Aug 2016; status: recruiting.
02
Drugs
ocriplasmin
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on MOH_2017-06-15_000119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-06-15_000119.